130 related articles for article (PubMed ID: 31157349)
21. Targeted delivery of quercetin loaded mesoporous silica nanoparticles to the breast cancer cells.
Sarkar A; Ghosh S; Chowdhury S; Pandey B; Sil PC
Biochim Biophys Acta; 2016 Oct; 1860(10):2065-75. PubMed ID: 27392941
[TBL] [Abstract][Full Text] [Related]
22. MUC1 aptamer-conjugated mesoporous silica nanoparticles effectively target breast cancer cells.
Hanafi-Bojd MY; Moosavian Kalat SA; Taghdisi SM; Ansari L; Abnous K; Malaekeh-Nikouei B
Drug Dev Ind Pharm; 2018 Jan; 44(1):13-18. PubMed ID: 28832225
[TBL] [Abstract][Full Text] [Related]
23. Macroporous silica nanoparticles for delivering Bcl2-function converting peptide to treat multidrug resistant-cancer cells.
Xu W; Ge P; Niu B; Zhang X; Liu J; Xie J
J Colloid Interface Sci; 2018 Oct; 527():141-150. PubMed ID: 29787950
[TBL] [Abstract][Full Text] [Related]
24. Zinc oxide nanoparticles induce apoptosis and autophagy in human ovarian cancer cells.
Bai DP; Zhang XF; Zhang GL; Huang YF; Gurunathan S
Int J Nanomedicine; 2017; 12():6521-6535. PubMed ID: 28919752
[TBL] [Abstract][Full Text] [Related]
25. Flower-like curcumin-loaded folic acid-conjugated ZnO-MPA- βcyclodextrin nanostructures enhanced anticancer activity and cellular uptake of curcumin in breast cancer cells.
Ghaffari SB; Sarrafzadeh MH; Fakhroueian Z; Khorramizadeh MR
Mater Sci Eng C Mater Biol Appl; 2019 Oct; 103():109827. PubMed ID: 31349522
[TBL] [Abstract][Full Text] [Related]
26. A pH-sensitive delivery system based on N-succinyl chitosan-ZnO nanoparticles for improving antibacterial and anticancer activities of curcumin.
Ghaffari SB; Sarrafzadeh MH; Salami M; Khorramizadeh MR
Int J Biol Macromol; 2020 May; 151():428-440. PubMed ID: 32068061
[TBL] [Abstract][Full Text] [Related]
27. Targeted delivery and apoptosis induction activity of peptide-transferrin targeted mesoporous silica encapsulated resveratrol in MCF-7 cells.
Li D; Song C; Zhang J; Zhao X
J Pharm Pharmacol; 2023 Jan; 75(1):49-56. PubMed ID: 36173891
[TBL] [Abstract][Full Text] [Related]
28. A focal adhesion kinase inhibitor 16-hydroxy-cleroda-3,13-dien-16,15-olide incorporated into enteric-coated nanoparticles for controlled anti-glioma drug delivery.
Thiyagarajan V; Lin SX; Lee CH; Weng CF
Colloids Surf B Biointerfaces; 2016 May; 141():120-131. PubMed ID: 26851441
[TBL] [Abstract][Full Text] [Related]
29. Synthesis, Characterization, and Assessment of Anti-Cancer Potential of ZnO Nanoparticles in an In Vitro Model of Breast Cancer.
Aljabali AAA; Obeid MA; Bakshi HA; Alshaer W; Ennab RM; Al-Trad B; Al Khateeb W; Al-Batayneh KM; Al-Kadash A; Alsotari S; Nsairat H; Tambuwala MM
Molecules; 2022 Mar; 27(6):. PubMed ID: 35335190
[TBL] [Abstract][Full Text] [Related]
30. Photoluminescent And Self-Assembled Hyaluronic Acid-Zinc Oxide-Ginsenoside Rh2 Nanoparticles And Their Potential Caspase-9 Apoptotic Mechanism Towards Cancer Cell Lines.
Kim YJ; Perumalsamy H; Castro-Aceituno V; Kim D; Markus J; Lee S; Kim S; Liu Y; Yang DC
Int J Nanomedicine; 2019; 14():8195-8208. PubMed ID: 31632027
[TBL] [Abstract][Full Text] [Related]
31. Redox/pH dual stimuli-responsive ZnO QDs-gated mesoporous silica nanoparticles as carriers in cancer therapy.
Wang W; Wang Y; Wang Y; Gong H; Zhu H; Liu M
IET Nanobiotechnol; 2019 Aug; 13(6):640-649. PubMed ID: 31432799
[TBL] [Abstract][Full Text] [Related]
32. Chitosan capped ZnO nanoparticles with cell specific apoptosis induction through P53 activation and G2/M arrest in breast cancer cells - In vitro approaches.
Anitha J; Selvakumar R; Murugan K
Int J Biol Macromol; 2019 Sep; 136():686-696. PubMed ID: 31212046
[TBL] [Abstract][Full Text] [Related]
33. Mechanistic Study on Thymoquinone Conjugated ZnO Nanoparticles Mediated Cytotoxicity and Anticancer Activity in Triple-Negative Breast Cancer Cells.
Banupriya SK; Kavithaa K; Poornima A; Sumathi S
Anticancer Agents Med Chem; 2022; 22(2):313-327. PubMed ID: 33845751
[TBL] [Abstract][Full Text] [Related]
34. SnO
Ahamed M; Akhtar MJ; Khan MAM; Alhadlaq HA
Int J Nanomedicine; 2021; 16():89-104. PubMed ID: 33447029
[TBL] [Abstract][Full Text] [Related]
35. Synthesis, characterization and in vitro study of biocompatible cinnamaldehyde functionalized magnetite nanoparticles (CPGF Nps) for hyperthermia and drug delivery applications in breast cancer.
Wani KD; Kadu BS; Mansara P; Gupta P; Deore AV; Chikate RC; Poddar P; Dhole SD; Kaul-Ghanekar R
PLoS One; 2014; 9(9):e107315. PubMed ID: 25268975
[TBL] [Abstract][Full Text] [Related]
36. Biological therapeutics of Pongamia pinnata coated zinc oxide nanoparticles against clinically important pathogenic bacteria, fungi and MCF-7 breast cancer cells.
Malaikozhundan B; Vaseeharan B; Vijayakumar S; Pandiselvi K; Kalanjiam MA; Murugan K; Benelli G
Microb Pathog; 2017 Mar; 104():268-277. PubMed ID: 28115262
[TBL] [Abstract][Full Text] [Related]
37. PNIPAAm-MAA nanoparticles as delivery vehicles for curcumin against MCF-7 breast cancer cells.
Zeighamian V; Darabi M; Akbarzadeh A; Rahmati-Yamchi M; Zarghami N; Badrzadeh F; Salehi R; Mirakabad FS; Taheri-Anganeh M
Artif Cells Nanomed Biotechnol; 2016; 44(2):735-42. PubMed ID: 25819738
[TBL] [Abstract][Full Text] [Related]
38. Biosynthesis of zinc oxide nanoparticles using anjbar (root of
Safavi E; Homayouni-Tabrizi M; Karimi E; Rahimi Kalateh Shah Mohammad G
IET Nanobiotechnol; 2019 Sep; 13(7):736-741. PubMed ID: 31573543
[TBL] [Abstract][Full Text] [Related]
39. Zinc oxide nanoparticles selectively induce apoptosis in human cancer cells through reactive oxygen species.
Akhtar MJ; Ahamed M; Kumar S; Khan MM; Ahmad J; Alrokayan SA
Int J Nanomedicine; 2012; 7():845-57. PubMed ID: 22393286
[TBL] [Abstract][Full Text] [Related]
40. Folic acid (FA)-conjugated mesoporous silica nanoparticles combined with MRP-1 siRNA improves the suppressive effects of myricetin on non-small cell lung cancer (NSCLC).
Song Y; Zhou B; Du X; Wang Y; Zhang J; Ai Y; Xia Z; Zhao G
Biomed Pharmacother; 2020 May; 125():109561. PubMed ID: 32106385
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
